These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 27312863)

  • 1. Physiological and pathophysiological bone turnover - role of the immune system.
    Weitzmann MN; Ofotokun I
    Nat Rev Endocrinol; 2016 Sep; 12(9):518-32. PubMed ID: 27312863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital Metabolic Bone Disorders as a Cause of Bone Fragility.
    Marini F; Giusti F; Iantomasi T; Brandi ML
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal osteoporosis: the role of immune system cells.
    Faienza MF; Ventura A; Marzano F; Cavallo L
    Clin Dev Immunol; 2013; 2013():575936. PubMed ID: 23762093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover: Biology and assessment tools.
    Szulc P
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):725-738. PubMed ID: 30449551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Regulation of bone homeostasis by nerve system].
    Fukuda T; Takeda S
    Clin Calcium; 2013 Sep; 23(9):1279-83. PubMed ID: 23999363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reducing bone resorption by cathepsin K inhibitor and treatment of osteoporosis].
    Watanabe R; Okazaki R
    Clin Calcium; 2014 Jan; 24(1):59-67. PubMed ID: 24369281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of bone turnover: consideration on their clinical application in osteoporosis.
    Cantatore FP; Pipitone V
    Panminerva Med; 1999 Sep; 41(3):247-51. PubMed ID: 10568124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone and the Immune System.
    Weitzmann MN
    Toxicol Pathol; 2017 Oct; 45(7):911-924. PubMed ID: 29046115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of biochemical markers of bone remodeling: current status and future directions.
    Looker AC; Bauer DC; Chesnut CH; Gundberg CM; Hochberg MC; Klee G; Kleerekoper M; Watts NB; Bell NH
    Osteoporos Int; 2000; 11(6):467-80. PubMed ID: 10982161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using biochemical markers of bone turnover in clinical practice.
    Singer FR; Eyre DR
    Cleve Clin J Med; 2008 Oct; 75(10):739-50. PubMed ID: 18939390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prediction of three-dimensional bone architecture in simulations of pre-, peri- and post-menopausal microstructural bone remodeling.
    Müller R
    Osteoporos Int; 2005 Mar; 16 Suppl 2():S25-35. PubMed ID: 15340800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of biochemical markers of bone turnover.
    Seibel MJ
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):603-20. PubMed ID: 17117286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in men.
    Seeman E
    Baillieres Clin Rheumatol; 1997 Aug; 11(3):613-29. PubMed ID: 9367040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiology and bone physiopathology].
    Lafita J
    An Sist Sanit Navar; 2003; 26 Suppl 3():7-15. PubMed ID: 14716355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus.
    Hough FS; Pierroz DD; Cooper C; Ferrari SL;
    Eur J Endocrinol; 2016 Apr; 174(4):R127-38. PubMed ID: 26537861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone turnover markers in the management of postmenopausal osteoporosis.
    Brown JP; Albert C; Nassar BA; Adachi JD; Cole D; Davison KS; Dooley KC; Don-Wauchope A; Douville P; Hanley DA; Jamal SA; Josse R; Kaiser S; Krahn J; Krause R; Kremer R; Lepage R; Letendre E; Morin S; Ooi DS; Papaioaonnou A; Ste-Marie LG
    Clin Biochem; 2009 Jul; 42(10-11):929-42. PubMed ID: 19362543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV: inflammation and bone.
    Ofotokun I; McIntosh E; Weitzmann MN
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):16-25. PubMed ID: 22179898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.
    Delmas PD; Eastell R; Garnero P; Seibel MJ; Stepan J;
    Osteoporos Int; 2000; 11 Suppl 6():S2-17. PubMed ID: 11193237
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption.
    Togari A; Arai M
    J Pharmacol Sci; 2008 Apr; 106(4):542-6. PubMed ID: 18431037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.